Ensayos clínicos de Migraña en Florida
12 estudios sobre Migraña buscan participantes en Florida.
Ciudades en Florida
Texto oficial del estudio (inglés)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- y 1 más
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- y 1 más
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 16 sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- y 9 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- y 4 más
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07616128Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07646613A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave, Hialeah
- University of South Florida, Tampa
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 12 jun 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Homestead Associates in Research, Inc., Homestead
- Florida Neurology - Lake Mary, Lake Mary
- Flourish Research - Miami, LLC dba Flourish Research, Miami
- y 2 más
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 19 may 2026 · NCT06602479Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
ReclutandoFase 4
Edades de 6 a 11 · Todos los sexos · Actualizado el 27 ene 2025 · NCT04748601De ClinicalTrials.gov, datos obtenidos el 2 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.